Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents.
about
Protein disulfide isomerase a multifunctional protein with multiple physiological rolesComplement-Coagulation Cross-Talk: A Potential Mediator of the Physiological Activation of Complement by Low pHA substrate-driven allosteric switch that enhances PDI catalytic activityThe C-terminal CGHC motif of protein disulfide isomerase supports thrombosis.A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.Vascular thiol isomerases.Dynamin-related protein-1 controls fusion pore dynamics during platelet granule exocytosis.Differential proteomics study of platelets in asymptomatic constitutional macrothrombocytopenia: altered levels of cytoskeletal proteins.HPW-RX40 prevents human platelet activation by attenuating cell surface protein disulfide isomerases.Thiol isomerases in thrombus formation.Ruthenium-conjugated chrysin analogues modulate platelet activity, thrombus formation and haemostasis with enhanced efficacyPlatelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS.Small molecule-induced oxidation of protein disulfide isomerase is neuroprotective.Revisiting the mechanistic basis of the French Paradox: Red wine inhibits the activity of protein disulfide isomerase in vitro.Fruitflow®: the first European Food Safety Authority-approved natural cardio-protective functional ingredient.Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis.Therapeutic implications of protein disulfide isomerase inhibition in thrombotic disease.Analysis of the isomerase and chaperone-like activities of an amebic PDI (EhPDI).The nairovirus nairobi sheep disease virus/ganjam virus induces the translocation of protein disulphide isomerase-like oxidoreductases from the endoplasmic reticulum to the cell surface and the extracellular space.Defective PDI release from platelets and endothelial cells impairs thrombus formation in Hermansky-Pudlak syndromeBoth platelet- and endothelial cell-derived ERp5 support thrombus formation in a laser-induced mouse model of thrombosis.Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.Novel roles for protein disulphide isomerase in disease states: a double edged sword?Platelet-targeting thiol reduction sensor detects thiol isomerase activity on activated platelets in mouse and human blood under flowVAMP-7 links granule exocytosis to actin reorganization during platelet activation.Broad-spectrum antivirals against viral fusion.Quercetin-3-rutinoside Inhibits Protein Disulfide Isomerase by Binding to Its b'x Domain.Thioredoxin Inhibitors Attenuate Platelet Function and Thrombus Formation.Anti-Proliferative Effects of Rutin on OLETF Rat Vascular Smooth Muscle Cells Stimulated by Glucose Variability.Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase.Protein disulfide isomerase as an antithrombotic targetProtein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation.Protein disulfide isomerase secretion following vascular injury initiates a regulatory pathway for thrombus formation.Control of blood proteins by functional disulfide bonds.Formation of the clot.Immunoregulation through membrane proteins modified by reducing conditions induced by immune reactions.Encryption and decryption of tissue factor.Nox NADPH oxidases and the endoplasmic reticulumMethods of measuring protein disulfide isomerase activity: a critical overview.An ERp57-mediated disulphide exchange promotes the interaction between Burkholderia cenocepacia and epithelial respiratory cells
P2860
Q27022009-AA8EB62D-AE8E-4CE5-B528-C303DCFA21CDQ27027361-BE2484EB-058E-44DA-AC4A-BA77110AAEE0Q27331600-CE82D490-2CF7-4119-9286-6B3FDBA2A283Q27332350-C1D61AC8-E984-4F9B-8F24-FE2A630B388FQ30388279-8DFC6940-554B-4165-BE37-75BED57184B6Q30389957-C2B370F9-6E6E-4BB4-BBC4-468B3C7C3F54Q30535815-DD7D7CA1-C6AC-4B39-8841-EE536E2BEC1BQ33415954-0A4B6B6A-6572-486D-AC39-A5CCAD0358B2Q33784320-0E4353D4-D9E7-4A8A-91C5-36B8B79B242DQ33792729-33E60396-FC1B-4E16-BA20-260AECB75BE9Q33915894-D8B45DAC-0AF2-490E-A2A8-B7ADAD6978AFQ33948737-3C92C95E-E614-4B21-B7E2-5E9D25EA7F7EQ34470561-1EC9C3D5-0DA1-49C9-AC0B-21B02FDEC69CQ34502286-AC6E2D71-7C49-4DE1-8A58-0876B0DF1D4DQ34533314-DBBF9FE3-5EA2-4093-98BE-BDF3CD84F8ACQ34551176-7DF71729-5475-4282-A9C4-CAF80309406DQ34734810-4A23D510-0451-47AC-94AF-6C1581B77D5CQ35074321-30E95CB5-B15D-4720-B5A3-D917B77AD5EAQ35143016-7A9BF368-FBAF-4C1E-8AE4-95C039ABC28CQ35153224-6CBA7E10-3EF5-43C0-A080-54CBBECE4F46Q35252672-D86E0D6A-6D14-4988-980A-85DE24A21E64Q35621012-17C8E5D5-7877-402B-8A2C-BA7FDAB58B2CQ35630891-1EE4A087-BA6C-46DB-B449-9DC01EDE4E03Q35883546-79B121DC-AE75-4F5A-8FF0-3CFC8BCA5A49Q35904952-49BAB5DF-23A9-44CA-B87D-BE1AD73E1539Q36010083-2CDD97AE-FED9-4A1B-9920-FF76BCCBD309Q36092979-4676B95C-D1D5-4AC7-B321-4F52EEA5E83CQ36157499-5A25E921-ADA5-4CE1-8610-167907D23A9CQ36541560-3396E4E2-A8F2-49D5-B81D-62307FD893CDQ36709845-1F821DE5-91CB-44AD-835F-24A63B772860Q36981253-0E0E0330-F13A-482D-AA60-6F123DA5FFBCQ37558713-92059898-A217-4E63-AE72-7F3C1262D434Q37660657-235891BC-1A1D-43B2-AFCB-DE24508E0C93Q37670056-33D54941-D33A-4B77-B67C-EF4A5DD1D428Q38048534-EB35F3F3-5777-47D9-9116-435CE8B60A3AQ38066808-D4413A3D-4227-4BD4-B333-6E6FEBAFC794Q38117739-10F051AE-5852-4C43-A568-B6783DFFDA5CQ38175423-7A6FDE59-BBB4-45F2-8EA1-6E5E56C18145Q38251838-A98E0E38-781B-4661-88F9-1BD1E9209CD0Q38480787-6D897FB3-0AB3-4D5F-8CE6-86B12D00E2FE
P2860
Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents.
@ast
Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents.
@en
type
label
Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents.
@ast
Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents.
@en
prefLabel
Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents.
@ast
Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents.
@en
P2093
P2860
P356
P1476
Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents.
@en
P2093
Barbara C Furie
Bruce Furie
Daniel R Kennedy
Freda H Passam
James R Dilks
Lotte van Hessem
Reema Jasuja
Robert Flaumenhaft
Sarah H Kim
P2860
P304
P356
10.1172/JCI61228
P407
P577
2012-05-08T00:00:00Z